Let-7 microRNAs and opioid tolerance

Frontiers in Genetics

Volumn 3, Issue JUN, 2012, Pages

  He, Ying ^a   Wang, Zaijie Jim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Addiction; Epigenetics; MiR; Opioid; Pain

Indexed keywords

CAENORHABDITIS ELEGANS;

EID: 84873501503     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00110     Document Type: Review

References (79)

1. Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355.
2. Baek, D., Villen, J., Shin, C., Camargo, F. D., Gygi, S. P., and Bartel, D. P. (2008). The impact of microRNAs on protein output. Nature 455, 64-71.
3. Bailey, C. P., and Connor, M. (2005). Opioids: cellular mechanisms of tolerance and physical dependence. Curr. Opin. Pharmacol. 5, 60-68.
4. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136,215-233.
5. Bernstein, M. A., and Welch, S. P. (1998). mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res. Mol. Brain Res. 55,237-242.
6. Bhargava, H. N., and Gulati, A. (1990). Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. Eur. J. Pharmacol. 190, 305-311.
7. Boyerinas, B., Park, S. M., Hau, A., Murmann, A. E., and Peter, M. E. (2010). The role of let-7 in cell differentiation and cancer. Endocr. Relat. Cancer 17, F19-F36.
8. Brodsky, M., Elliott, K., Hynansky, A., and Inturrisi, C. E. (1995). CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone. Brain Res. Bull. 38,135-141.
9. Carlezon, W. A. Jr., Duman, R. S., and Nestler, E. J. (2005). The many faces of CREB. Trends Neurosci. 28, 436-445.
10. Chakrabarti, S., Yang, W., Law, P. Y., and Loh, H. H. (1997). The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation. Mol. Pharmacol. 52,105-113.
11. Chan, K. W., Duttory, A., and Yoburn, B. C. (1997). Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density. Eur. J. Pharmacol. 319,225-228.
12. Chi, S. W., Hannon, G. J., and Darnell, R. B. (2012). An alternative mode ofmicroRNA target recognition. Nat. Struct. Mol. Biol. 19, 321-327.
13. Childs, G., Fazzari, M., Kung, G., Kawachi, N., Brandwein-Gensler, M., McLemore, M., Chen, Q., Burk, R. D., Smith, R. V., Prystowsky, M. B., Belbin, T. J., and Schlecht, N. F. (2009). Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am. J. Pathol. 174,736-745.
14. Dahiya, N., Sherman-Baust, C. A., Wang, T. L., Davidson, B., Shih Ie, M., Zhang, Y., Wood, W III, Becker, K. G., and Morin, P. J. (2008). MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 3, e2436. doi:10.1371/journal.pone.0002436
15. Dave, R. S., and Khalili, K. (2010). Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system. J. Cell. Biochem. 110,834-845.
16. Davis, M. E., Akera, T., and Brody, T. M. (1979). Reduction of opiate binding to brainstem slices associated with the development of tolerance to morphine in rats. J. Pharmacol. Exp. Ther.211, 112-119.
17. Diaz, A., Pazos, A., Florez, J., and Hurle, M. A. (2000). Autoradiographic mapping of mu-opioid receptors during opiate tolerance and super-sensitivity in the rat central nervous system. Naunyn SchmiedebergsArch. Pharmacol. 362,101-109.
18. Didiano, D., and Hobert, O. (2006). Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat. Struct. Mol. Biol. 13,849-851.
19. Dum, J., Meyer, G., Hollt, V., and Herz, A. (1979). In vivo opiate binding unchanged in tolerant/dependent mice. Eur. J. Pharmacol. 58,453-460.
20. Easow, G., Teleman, A. A., and Cohen, S. M. (2007). Isolation of microRNA targets by miRNP immunopurification. RNA 13, 1198-1204.
21. Guled, M., Lahti, L., Lindholm, P. M., Salmenkivi, K., Bagwan, I., Nicholson, A. G., and Knuutila, S. (2009).CDKN2A, NF2, and JUN are dysregulated among other genes by miR-NAs in malignant mesothelioma-A miRNA microarray analysis. Genes Chromosomes Cancer 48, 615-623
22. Guo, J. U., Su, Y., Zhong, C., Ming, G. L., and Song, H. (2011). Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145, 423-434.
23. Ha, I., Wightman, B., and Ruvkun, G. (1996). A bulged lin-4/lin-14 RNA duplex is sufficient for Caenorhabditis elegans lin-14 temporal gradient formation. Genes Dev. 10, 3041-3050.
24. Han, W., Kasai, S., Hata, H., Takahashi, T., Takamatsu, Y., Yamamoto, H., Uhl, G. R., Sora, I., and Ikeda, K. (2006). Intracisternal a-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity. Pharmacogenet. Genomics 16,451-460.
25. Harden, R. N. (2008). Chronic pain and opiates: a call for moderation. Arch. Phys. Med. Rehabil. 89, S72-S76..
26. He, Y., Yang, C., Kirkmire, C. M., and Wang, Z. J. (2010). Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J. Neurosci. 30, 10251-10258.
27. Ide, S., Han, W., Kasai, S., Hata, H., Sora, I., and Ikeda, K. (2005). Characterization of the 3' untranslated region of the human mu-opioid receptor (MOR-1) mRNA. Gene 364, 139-145.
28. Johnson, E. E., Chieng, B., Napier, I., and Connor, M. (2006). Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice. Br. J. Pharmacol. 148, 947-955.
29. Kieffer, B. L., and Evans, C. J. (2002). Opioid tolerance-in search of the holy grail. Cell 108, 587-590.
30. Koch, T., and Hollt, V. (2008). Role of receptor internalization in opioid tolerance and dependence. Pharmacol. Ther. 117, 199-206.
31. Kosik, K. S. (2006). The neuronal microRNA system. Nat. Rev. Neurosci. 7,911-920.
32. Lee, Y S., and Dutta, A. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21, 1025-1030.
33. Lewis, J. W., Lewis, M. E., Loomus, D. J., and Akil, H. (1984). Acute systemic administration of morphine selectively increases mu opioid receptor binding in the rat brain. Neuropeptides 5, 117-120.
34. Lopez-Gimenez, J. F., and Milligan, G. (2010). Opioid regulation of mu receptor internalisation: relevance to the development of tolerance and dependence. CNS Neurol. Disord. Drug Targets 9, 616-626.
35. Mansfield, J. H., Harfe, B. D., Nissen, R., Obenauer, J., Srineel, J., Chaudhuri, A., Farzan-Kashani, R., Zuker, M., Pasquinelli, A. E., Ruvkun, G., Sharp, P. A., Tabin, C. J., and McManus, M. T. (2004). MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat. Genet. 36, 1079-1083.
36. Martini, L., and Whistler, J. L. (2007). The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr. Opin. Neurobiol. 17, 556-564.
37. Matthes, H. W., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dolle, P., Tzavara, E., Hanoune, J., Roques, B. P., and Kieffer, B. L. (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383,819-823.
38. Mayr, C., Hemann, M. T., and Bartel, D. P. (2007). Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576-1579.
39. McQuay, H. (1999). Opioids in pain management. Lancet 353, 2229-2232.
40. Mourelatos, Z. (2008). Small RNAs: the seeds of silence. Nature 455, 44-45.
41. Nishino, K., Su, Y. F., Wong, C. S., Watkins, W. D., and Chang, K. J. (1990). Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord. J. Pharmacol Exp. Ther. 253, 67-72.
42. Pasquinelli, A. E., Reinhart, B. J., Slack, E, Martindale, M. Q., Kuroda, M. I., Maller, B., Hayward, D. C., Ball, E. E., Degnan, B., Muller, P., Spring, J., Srinivasan, A., Fishman, M., Finnerty, J., Corbo, J., Levine, M., Leahy, P., Davidson, E., and Ruvkun, G. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86-89.
43. Peng, Y., Laser, J., Shi, G., Mittal, K., Melamed, J., Lee, P., and Wei, J. J. (2008). Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol. Cancer Res. 6,663-673.
44. Pietrzykowski, A. Z. (2011). The role of microRNAs in drug addiction: a big lesson from tiny molecules. Int. Rev. Neurobiol. 91,1-24.
45. Pillai, R. S., Bhattacharyya, S. N., Artus, C. G., Zoller, T., Cougot, N., Basyuk, E., Bertrand, E., and Filipowicz, W (2005). Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573-1576.
46. Qian, Z. R., Asa, S. L., Siomi, H., Siomi,M. C.,Yoshimoto,K.,Yamada, S., Wang, E. L., Rahman, M. M., Inoue, H., Itakura, M., Kudo, E., and Sano, T. (2009). Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod. Pathol. 22,431-441.
47. Reinhart, B. J., Slack, E J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., and Ruvkun, G. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906.
48. Renthal, W., Carle, T. L., Maze, I., Covington, H. E. III, Truong, H. T., Alibhai, I., Kumar, A., Montgomery, R. L., Olson, E. N., and Nestler, E. J. (2008). Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure.J. Neurosci. 28,7344-7349.
49. Robison, A. J., and Nestler, E. J. (2011). Transcriptional and epigenetic mechanisms of addiction. Nat. Rev. Neurosci. 12, 623-637.
50. Roush, S., and Slack, E J. (2008). The let-7 family of microRNAs. Trends Cell Biol. 18,505-516.
51. Ruby, J. G., Jan, C., Player, C., Axtell, M. J., Lee, W., Nusbaum, C., Ge, H.,and Bartel, D. P. (2006). Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 127, 1193-1207.
52. Sanchez-Simon, F. M., Zhang, X. X., Loh, H. H., Law, P. Y., and Rodriguez, R. E. (2010). Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol. Pharmacol. 78, 935-942.
53. Schulman, B. R., Esquela-Kerscher, A., and Slack, F. J. (2005). Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Dev. Dyn. 234, 1046-1054.
54. Selbach, M., Schwanhausser, B., Thier-felder, N., Fang, Z., Khanin, R., and Rajewsky, N. (2008). Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63.
55. Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., and Ambros, V. (2004). Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5,R13.
56. Shell, S., Park, S. M., Radjabi, A. R., Schickel, R., Kistner, E. O., Jewell, D. A., Feig, C., Lengyel, E., and Peter, M. E. (2007). Let-7 expression defines two differentiation stages of cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 11400-11405.
57. Sim, L. J., Selley, D. E., Dworkin, S. I., and Childers, S. R. (1996). Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J. Neurosci. 16, 2684-2692.
58. Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R. S., Donovan, D. M., Miner, L. L., and Uhl, G. R. (1997). Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U.S.A. 94, 1544-1549.
59. Stefani, G., and Slack, F.J. (2012). A'pivotal' new rule for microRNA-mRNA interactions. Nat. Struct. Mol. Biol. 19,265-266.
60. Sun, T., Fu, M., Bookout, A. L., Kliewer, S. A., and Mangelsdorf, D. J. (2009). MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol. Endocrinol. 23, 925-931.
61. Taft, R. J., Pang, K. C., Mercer, T. R., Dinger, M., and Mattick, J. S. (2010). Non-coding RNAs: regulators of disease.J. Pathol. 220,126-139.
62. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M.,Nimura, Y., Mitsudomi, T., and Takahashi, T. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753-3756.
63. Tao, P. L., Law, P. Y., and Loh, H. H. (1987). Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J. Pharmacol. Exp. Ther. 240,809-816.
64. Tay, Y., Zhang, J., Thomson, A. M., Lim, B.,andRigoutsos,I. (2008). MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124-1128.
65. Tempel, A., Habas, J., Paredes, W., and Barr, G. A. (1988). Morphine-induced downregulation of mu-opioid receptors in neonatal rat brain. Brain Res. 469,129-133.
66. Thomson, J. M., Newman, M., Parker, J. S., Morin-Kensicki, E. M., Wright, T., and Hammond, S. M. (2006). Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20, 2202-2207.
67. Thomson, J. M., Parker, J., Perou, C. M., and Hammond, S. M. (2004). A custom microarray platform for analysis of microRNA gene expression. Nat. Methods 1,47-53.
68. Ueda, H., and Ueda, M. (2009). Mechanisms underlying morphine analgesic tolerance and dependence. Front. Biosci. 14, 5260-5272.
69. Vella, M. C., Choi, E. Y., Lin, S. Y., Reinert, K., and Slack, F. J. (2004). The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3 UTR. Genes Dev. 18, 132-137.
70. Wang, Z. J., and Wang, L. X. (2006). Phosphorylation: amolecular switch in opioid tolerance. Life Sci. 79, 1681-1691.
71. Wong, C. S., Cherng, C. H., Luk, H. N., Ho, S. T., and Tung, C. S. (1996). Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Eur. J. Pharmacol. 297, 27-33.
72. Wu, Q., Law, P. Y., Wei, L. N., and Loh, H. H. (2008). Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b. FASEB J. 22, 4085-4095.
73. Wu, Q., Zhang, L., Law, P. Y., Wei, L. N., and Loh, H. H. (2009). Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol. Pharmacol. 75, 744-750.
74. Wulczyn, F. G., Smirnova, L., Rybak, A., Brandt, C., Kwidzinski, E., Ninnemann, O., Strehle, M., Seiler, A., Schumacher, S., and Nitsch, R. (2007). Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB/21, 415-426.
75. Zachariou, V. Bolanos, C. A., Selley, D.E., Theobald, D., Cassidy, M. P.Kelz, M. B., Shaw-Lutchman, T. Berton, O. Sim-Selley, L. J., Dileone, R. J., Kumar, A., and Nestler, E.J. (2006). An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat. Neurosci. 9, 205-211.
76. Zadina, J. E., Chang, S. L., Ge, L. J., and Kastin, A. J. (1993). Mu opiate receptor down-regulation by morphine and up-regulation by nalox-one in SH-SY5Y human neuroblastoma cells.J.Pharmacol. Exp. Ther. 265, 254-262.
77. Zheng, H., Zeng, Y., Zhang, X., Chu, J., Loh, H. H., and Law, P. Y (2010). mu-Opioid receptor agonists differentially regulate the expression of miR-190 andNeuroD. Mol. Pharmacol. 77, 102-109.
78. Zhou,X.,Benson, K.F.,Ashar,H.R.,and Chada, K. (1995). Mutation responsible for the mouse pygmy pheno-type in the developmentally regulated factor HMGI-C. Nature 376, 771-774.
79. Zollner, C., Johnson, P. S., Bei Wang, J., Roy, A. J. Jr., Layton, K. M., Min Wu, J., and Surratt, C. K. (2000). Control of mu opioid receptor expression by modification of cDNA 5;-and 3;-noncoding regions. Brain Res. Mol. Brain Res. 79, 159-162.